My watch list

HLA-DR3



major histocompatibility complex, class II, DR3
Haplotypes groups	DRA01:DRB10301 DRA01:DRB10302 DRA01:DRB10303 DRA01:DRB10304
Structure (See HLA-DR)
Identifiers	alpha *0101
Symbol(s)	HLA-DRA
EBI-HLA	DRA*0101
Identifiers	beta 1 0301 0301 0302 0303 *0304
Symbol(s)	HLA-DRB1
EBI-HLA	DRB1*0301
EBI-HLA	DRB1*0302
EBI-HLA	DRB1*0303
EBI-HLA	DRB1*0304
EBI-HLA	DRB1*0305
Shared data
Locus	chr.6 6p21.31

HLA-DR3 is composed to the HLA-DR17 and HLA-DR18 split 'antigens' serotypes.

Additional recommended knowledge

How to ensure accurate weighing results every day?

What is the Sensitivity of my Balance?

What is the Correct Way to Check Repeatability in Balances?

1 Serology
2 Disease associations
3 Genetic linkage
4 References

Serology

DR17 and DR3 recognition of some DRB1*03 alleles^[1]
DRB1*	DR3	DR17	DR18	Sample
allele	%	%	%	size (N)
0301	33	64	0	9698
0302	24	3	66	317
0303	40		60	5
0304	60	20		5
0307	>50			1

Some DR3 also react with HLA-DR17 and/or HLA-DR18. The DRB1*0304 primarily reacts with DR3. The serotypes of *0305, *0306, *0308 to *0331 are unknown.

Disease associations

By serotype

HLA-DR3 is associated with early-age onset myasthenia gravis, primary sclerosing cholangitis,^[2] and opportunistic infections in AIDS^[3], but lowered risk for cancers^[4].

By allele

DRB1*0301 (see HLA-DR17)

DRB1*0302 (See HLA-DR18)

DRB1*0304 is associated it graves disease^[5]

By haplotypes

DR3 and/or DQ2 is associated with Moreen's ulceration^[6], "bout onset" multiple sclerosis^[7], Grave's disease^[8] and systemic lupus erythematosus^[9]

DR3-DQ2 linkage is associated with coeliac disease, dermatitis herpetiformis, juvenile diabetes. DR3-DR2 is the serological marker for HLA-DQ2.5cis isoform. Although it cannot identify the alpha ".5" chain of HLA DQ, DQA1*0501 gene is almost always found within the DR3-DQ2 haplotype Eurasia (however is older studies DQA1*0505 is commonly confused with DQA1*0501)
PubMed

Genetic linkage

DR3 is genetically linked to HLA-DR52, DRB3*0202 allele, and HLA-DQ2 (DQ2.5).

References

^ derived from IMGT/HLA
^ Wiencke K, Karlsen TH, Boberg KM, et al (2007). "Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes". Tissue Antigens 69 (2): 161-9. doi:10.1111/j.1399-0039.2006.00738.x. PMID 17257319.
^ Pollack MS, Gold J, Metroka CE, Safai B, Dupont B (1984). "HLA-A,B,C and DR antigen frequencies in acquired immunodeficiency syndrome (AIDS) patients with opportunistic infections". Hum. Immunol. 11 (2): 99-103. PMID 6333416.
^ Mann DL, Murray C, O'Donnell M, Blattner WA, Goedert JJ (1990). "HLA antigen frequencies in HIV-1-related Kaposi's sarcoma". J. Acquir. Immune Defic. Syndr. 3 Suppl 1: S51-5. PMID 2395088.
^ "{{{title}}}". PMID 10468973.
^ Taylor C, Smith S, Morgan C, Stephenson S, Key T, Srinivasan M, Cunningham E, Watson P (2000). "HLA and Mooren's ulceration.". Br J Ophthalmol 84 (1): 72-5. PMID 10611103.
^ Weinshenker B, Santrach P, Bissonet A, McDonnell S, Schaid D, Moore S, Rodriguez M (1998). "Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study.". Neurology 51 (3): 742-7. PMID 9748020.
^ Ratanachaiyavong S, Lloyd L, Darke C, McGregor A (1993). "MHC-extended haplotypes in families of patients with Graves' disease.". Hum Immunol 36 (2): 99-111. PMID 8096501.
^ Tjernström F, Hellmer G, Nived O, Truedsson L, Sturfelt G (1999). "Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus.". Lupus 8 (2): 103-8. PMID 10192503.

v • d • e HLA DR Serotypes
DR - DR1 - DR2 - DR3 - DR4 - DR5 - DR6 - DR7 - DR8 - DR9 - DR10 - DR11 - DR12 - DR13 - DR14 - DR15 - DR16 - DR17 - DR18 - DR51 - DR52 - DR53

Category: HLA-DR haplotypes

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "HLA-DR3". A list of authors is available in Wikipedia.